TCRCure Biopharma Ltd. aims to develop next generation cancer immunotherapies that control tumor progression, convert cancers to manageable chronic diseases, and eventually lead to a cure.
TCRCure is a leading international company focused on streamlined biotechnology development including high throughput antigen-specific TCR cloning, industry scale virus production, T cell genetic engineering, and immune cell manufacturing.